Skip to content

TransCelerate Event

Webinar: Pharmacovigilance Agreement Solutions You Didn’t Realize You Needed

Watch this webinar for an overview of TransCelerate’s Pharmacovigilance Agreements Optimization (PVAO) Initiative, which includes a suite of solutions designed to help organizations enhance their PVA process. These solutions can help organizations improve their processes and potentially achieve more efficient negotiations with business partners globally. ​

The webinar includes: 

  • An overview of the Pharmacovigilance Agreements Optimization (PVAO) Initiative that could be used to inform and/or help streamline the end-to end PVA process.  ​
  • A deeper dive into the two most recent solutions: ​
    • Timelines Benchmarking: Aggregate benchmarking data on exchange timelines. ​
    • Audit Process Efficiencies: Suite of solutions providing marketing partner audit considerations. ​
  • Q&A will address audience questions on the PVAO solution. 

Slides can be viewed here. Watch the webinar here.


  • Yvonne Gibble, Executive Director, Pharmacovigilance Partner Strategy & Management, ​Merck Sharpe & Dohme, LLC 
  • Beth MacEntee Pileggi, Senior Director, Safety Information Management & Automation, Johnson & Johnson
  • Wendy Manko Singer,  Associate Vice President, Individual Case Medical Review, Global Clinical Safety & Pharmacovigilance, Merck Sharpe & Dohme, LLC
  • Jonathan Rowell, Senior Director, Head of Pharmacovigilance QA, ​Johnson & Johnson

Ideal Attendees:

  • Alliance Managers
  • Safety Scientists
  • Pharmacovigilance Managers, Officers, Associates, Specialists, Directors, 
  • Pharmacovigilance Licensing, Experts, Leads. ​
  • Safety Data Exchange Agreement Managers, Officers, Associates, Specialists, Directors,
  • Patient Safety Directors, Managers, Officers, Associates, Specialists,
  • Global and Local Patient Safety, Pharmacovigilance Country Head(s), QPPV, Local QPPV
  • Business Development and Licensing (BD&L) Directors, Associate Directors, Managers